Editorial: The Biological Landscape of Immunotherapy in AML.
作者信息
Isidori Alessandro, Daver Naval, Curti Antonio
机构信息
Hematology and Stem Cell Transplant Center, Azienda Ospedaliera Ospedali Riuniti Marche Nord (AORMN) Hospital, Pesaro, Italy.
Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States.
出版信息
Front Oncol. 2021 Apr 15;11:671252. doi: 10.3389/fonc.2021.671252. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: The Biological Landscape of Immunotherapy in AML.社论：急性髓系白血病免疫治疗的生物学前景
Front Oncol. 2021 Apr 15;11:671252. doi: 10.3389/fonc.2021.671252. eCollection 2021.
2
Harnessing the immune system in acute myeloid leukaemia.利用急性髓系白血病中的免疫系统。
Crit Rev Oncol Hematol. 2016 Jul;103:62-77. doi: 10.1016/j.critrevonc.2016.04.020. Epub 2016 May 11.
3
Acute myeloid leukaemia and the immune system: implications for immunotherapy.急性髓系白血病与免疫系统：免疫治疗的影响。
Br J Haematol. 2020 Jan;188(1):147-158. doi: 10.1111/bjh.16310. Epub 2019 Nov 29.
4
[Research Advance on the Immune Escape of Acute Myeloid Leukemia--Review].[急性髓系白血病免疫逃逸的研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Aug;28(4):1429-1432. doi: 10.19746/j.cnki.issn.1009-2137.2020.04.060.
5
Natural killer cell immune escape in acute myeloid leukemia.自然杀伤细胞免疫逃逸在急性髓系白血病中的作用。
Leukemia. 2012 Sep;26(9):2019-26. doi: 10.1038/leu.2012.87. Epub 2012 Mar 26.
6
Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.肿瘤反应性免疫细胞可抵御转移性肿瘤，并诱导惰性而非静止肿瘤细胞的免疫编辑。
J Leukoc Biol. 2016 Sep;100(3):625-35. doi: 10.1189/jlb.5A1215-580R. Epub 2016 Feb 29.
7
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.免疫抑制微环境在急性髓系白血病发生发展及治疗中的作用
Expert Rev Hematol. 2014 Dec;7(6):807-18. doi: 10.1586/17474086.2014.958464. Epub 2014 Sep 16.
8
The progress and current status of immunotherapy in acute myeloid leukemia.急性髓系白血病免疫治疗的进展与现状
Ann Hematol. 2017 Dec;96(12):1965-1982. doi: 10.1007/s00277-017-3148-x. Epub 2017 Oct 28.
9
Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets.免疫检查点抑制剂在急性髓系白血病中的应用：新型联合疗法与治疗靶点
Curr Oncol Rep. 2019 Mar 23;21(4):37. doi: 10.1007/s11912-019-0781-7.
10
[Novel therapies for pediatric acute myeloid leukemia: building future strategies through incorporation of treatment currently used in adults].小儿急性髓系白血病的新型疗法：通过纳入目前用于成人的治疗方法构建未来策略
Rinsho Ketsueki. 2020;61(6):665-672. doi: 10.11406/rinketsu.61.665.
引用本文的文献
1
Case Report: Immune dysregulation associated with long-lasting regression of a (pre)leukemic clone.病例报告：免疫失调与（前）白血病克隆的持久消退相关。
Front Immunol. 2023 Oct 16;14:1280885. doi: 10.3389/fimmu.2023.1280885. eCollection 2023.
2
Harnessing Immune Response in Acute Myeloid Leukemia.利用急性髓系白血病中的免疫反应
J Clin Med. 2023 Sep 7;12(18):5824. doi: 10.3390/jcm12185824.
3
Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis.与急性髓系白血病相关的免疫亚型的预后特征及其基于单细胞测序分析在细胞亚群中的鉴定。
Front Cell Dev Biol. 2022 Sep 23;10:990034. doi: 10.3389/fcell.2022.990034. eCollection 2022.
4
Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward.为儿童急性髓系白血病免疫治疗铺平道路：当前认知与未来方向
Cancers (Basel). 2021 Aug 28;13(17):4364. doi: 10.3390/cancers13174364.
本文引用的文献
1
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy.免疫风险评分可预测接受化疗的急性髓系白血病患者的生存情况。
Clin Cancer Res. 2021 Jan 1;27(1):255-266. doi: 10.1158/1078-0432.CCR-20-3417. Epub 2020 Dec 1.
2
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.鉴定出一种免疫特征，可预测肺腺癌患者的预后风险。
J Transl Med. 2019 Mar 4;17(1):70. doi: 10.1186/s12967-019-1824-4.
3
Leukemia Stem Cells Microenvironment.白血病干细胞微环境。
Adv Exp Med Biol. 2017;1041:19-32. doi: 10.1007/978-3-319-69194-7_3.
4
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
5
Conservation of immune gene signatures in solid tumors and prognostic implications.实体瘤中免疫基因特征的保守性及其预后意义。
BMC Cancer. 2016 Nov 22;16(1):911. doi: 10.1186/s12885-016-2948-z.
6
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.对纵向肿瘤样本中的免疫特征进行分析，有助于深入了解免疫检查点阻断反应的生物标志物和耐药机制。
Cancer Discov. 2016 Aug;6(8):827-37. doi: 10.1158/2159-8290.CD-15-1545. Epub 2016 Jun 14.
7
The prognostic landscape of genes and infiltrating immune cells across human cancers.人类癌症中基因与浸润性免疫细胞的预后情况
Nat Med. 2015 Aug;21(8):938-945. doi: 10.1038/nm.3909. Epub 2015 Jul 20.
8
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.基因组分析显示，在北中部癌症治疗组n9831辅助曲妥珠单抗试验中，免疫功能基因与临床结局密切相关。
J Clin Oncol. 2015 Mar 1;33(7):701-8. doi: 10.1200/JCO.2014.57.6298. Epub 2015 Jan 20.
9
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.免疫抑制微环境在急性髓系白血病发生发展及治疗中的作用
Expert Rev Hematol. 2014 Dec;7(6):807-18. doi: 10.1586/17474086.2014.958464. Epub 2014 Sep 16.
10
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.基于反映肿瘤和微环境的 2 个基因表达的弥漫性大 B 细胞淋巴瘤的生存预测。
Blood. 2011 Aug 4;118(5):1350-8. doi: 10.1182/blood-2011-03-345272. Epub 2011 Jun 13.
Zotero 插件